Literature DB >> 17172932

Recombinant human-activated protein C inhibits cardiomyocyte apoptosis in a rat model of myocardial ischemia-reperfusion.

Bahar Pirat1, Haldun Muderrisoglu, Muge Tecder Unal, Handan Ozdemir, Aylin Yildirir, Muammer Yucel, Suna Turkoglu.   

Abstract

OBJECTIVES: Myocardial apoptosis is recognized as a major mechanism of cell death during ischemia-reperfusion. In this study, we assessed the hypothesis that activated protein C may have a cardioprotective effect via preventing apoptosis in a rat model of myocardial ischemia-reperfusion.
METHODS: Thirty male Sprague-Dawley rats were anesthetized, instrumented for hemodynamic measurements and ventilated mechanically. Twenty rats were subjected to 20 min of left anterior descending coronary artery occlusion and 2 h of reperfusion. They were randomly assigned to receive intravenous Ringer lactate (vehicle) or activated protein C (2 mg/kg/h) 10 min after occlusion and during reperfusion. The other 10 rats were sham-operated. At the end of the reperfusion period, serum samples were obtained for evaluation of creatine kinase, C-reactive protein and tumor necrosis factor-alpha. Apoptosis was measured quantitatively by the terminal deoxynucleotide transferase-mediated dUTP nick-end labeling method.
RESULTS: Serum creatine kinase, C-reactive protein and tumor necrosis factor-alpha values and percentage of terminal deoxynucleotide transferase-mediated dUTP nick-end labeling- positive myocyte nuclei demonstrated negligible myocardial injury in sham-operated controls. During reperfusion, mean arterial pressures were significantly higher in activated protein C-treated rats than in the control group (68.2+/-10.3 vs. 55.4+/-11.6 mmHg, P=0.01). Number of apoptotic cells was significantly reduced from 47.7 to 24.8% with activated protein C administration (P=0.008). No difference was seen between activated protein C-treated and untreated animals with respect to creatine kinase, C-reactive protein and tumor necrosis factor-alpha levels.
CONCLUSIONS: Treatment with activated protein C significantly improved hemodynamics after ischemia-reperfusion and reduced ischemia-reperfusion-induced myocardial apoptosis in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17172932     DOI: 10.1097/MCA.0b013e328010a44a

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  15 in total

Review 1.  Activated protein C: biased for translation.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

2.  Activated protein C modulates cardiac metabolism and augments autophagy in the ischemic heart.

Authors:  R Costa; A Morrison; J Wang; C Manithody; J Li; A R Rezaie
Journal:  J Thromb Haemost       Date:  2012-09       Impact factor: 5.824

3.  Protein tyrosine phosphatase 1B (PTP1B) is required for cardiac lineage differentiation of mouse embryonic stem cells.

Authors:  Zahra Shokati Eshkiki; Mohammad Hossein Ghahremani; Parisa Shabani; Sattar Gorgani Firuzjaee; Asie Sadeghi; Hossein Ghanbarian; Reza Meshkani
Journal:  Mol Cell Biochem       Date:  2016-11-08       Impact factor: 3.396

4.  Activated protein C protects against myocardial ischemic/reperfusion injury through AMP-activated protein kinase signaling.

Authors:  J Wang; L Yang; A R Rezaie; J Li
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

5.  Activated protein C: a potential cardioprotective factor against ischemic injury during ischemia/reperfusion.

Authors:  Jingying Wang; Ji Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

6.  Activated protein C protects myocardium via activation of anti-apoptotic pathways of survival in ischemia-reperfused rat heart.

Authors:  Jia-Wang Ding; Xiao-Hong Tong; Jun Yang; Zhao-Qi Liu; Yan Zhang; Jian Yang; Song Li; Li Li
Journal:  J Korean Med Sci       Date:  2010-10-26       Impact factor: 2.153

7.  Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition.

Authors:  Sumra Nazir; Ihsan Gadi; Moh'd Mohanad Al-Dabet; Ahmed Elwakiel; Shrey Kohli; Sanchita Ghosh; Jayakumar Manoharan; Satish Ranjan; Fabian Bock; Ruediger C Braun-Dullaeus; Charles T Esmon; Tobias B Huber; Eric Camerer; Chris Dockendorff; John H Griffin; Berend Isermann; Khurrum Shahzad
Journal:  Blood       Date:  2017-09-07       Impact factor: 22.113

8.  Increase in activated protein C mediates acute traumatic coagulopathy in mice.

Authors:  Brian B Chesebro; Pamela Rahn; Michel Carles; Charles T Esmon; Jun Xu; Karim Brohi; Daniel Frith; Jean-François Pittet; Mitchell J Cohen
Journal:  Shock       Date:  2009-12       Impact factor: 3.454

Review 9.  Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies.

Authors:  Mingyuan Wu; Bengt Linderoth; Robert D Foreman
Journal:  Auton Neurosci       Date:  2008-02-29       Impact factor: 3.145

10.  Activated protein C has a protective effect against myocardial I/R injury by improvement of endothelial function and activation of AKT1.

Authors:  Yoshito Maehata; Shigeru Miyagawa; Yoshiki Sawa
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.